A Prospective Study of Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy for Siewert II ?III of Locally Advanced HER-2 Negative Adenocarcinoma at Gastroesophageal Junction
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 40
Summary
- Conditions
- Gastroesophageal Junction Adenocarcinoma
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 70 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03349866
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Qun Zhao Hebei Medical University Fourth Hospital Principal Investigator: Jun Wang Hebei Medical University Fourth Hospital
Get Well Soon